Net Income (Loss) Per Common Share (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of Net Income (Loss) Per Common Share

The following reflects the net income (loss) attributable to common shareholders and share data used in the basic and diluted net income (loss) per common share computations using the two-class method for the periods indicated:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share amounts)	2025		2024		2025		2024
Numerator:
Net income (loss)	$	708	$	(1,858)	$	(2,547)	$	(10,414)

Denominator:
Weighted average shares outstanding - basic	46,494,598		43,882,110		45,905,069		43,610,481
Weighted average shares outstanding - diluted	49,088,436		43,882,110		45,905,069		43,610,481

Net income (loss) per common share - basic	$	0.02	$	(0.04)	$	(0.06)	$	(0.24)
Net income (loss) per common share - diluted	$	0.01	$	(0.04)	$	(0.06)	$	(0.24)

Anti-dilutive shares excluded from the calculation of diluted income (loss) per share (1)
Stock options	551,652		1,678,775		728,199		3,077,373
Restricted and performance stock units	1,631,075		319,136		1,159,489		513,975

__________

(1)Common equivalent shares for the three months ended September 30, 2024 and nine months ended September 30, 2025 and 2024 are not included in the diluted per share calculations as they would be anti-dilutive if the Company were in a net income position.

Axogen, Inc. 10-Q